miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta.

The bicistronic microRNA (miRNA) locus miR-144/451 is highly expressed during erythrocyte development, although its physiological roles are poorly understood. We show that miR-144/451 ablation in mice causes mild erythrocyte instability and increased susceptibility to damage after exposure to oxidant drugs. This phenotype is deeply conserved, as miR-451 depletion synergizes with oxidant stress to cause profound anemia in zebrafish embryos. At least some protective activities of miR-451 stem from its ability to directly suppress production of 14-3-3zeta, a phospho-serine/threonine-binding protein that inhibits nuclear accumulation of transcription factor FoxO3, a positive regulator of erythroid anti-oxidant genes. Thus, in miR-144/451(-/-) erythroblasts, 14-3-3zeta accumulates, causing partial relocalization of FoxO3 from nucleus to cytoplasm with dampening of its transcriptional program, including anti-oxidant-encoding genes Cat and Gpx1. Supporting this mechanism, overexpression of 14-3-3zeta in erythroid cells and fibroblasts inhibits nuclear localization and activity of FoxO3. Moreover, shRNA suppression of 14-3-3zeta protects miR-144/451(-/-) erythrocytes against peroxide-induced destruction, and restores catalase activity. Our findings define a novel miRNA-regulated pathway that protects erythrocytes against oxidant stress, and, more generally, illustrate how a miRNA can influence gene expression by altering the activity of a key transcription factor.

[1]  Xiaoxia Qi,et al.  Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3zeta. , 2010, Genes & development.

[2]  David W. Taylor,et al.  A Novel miRNA Processing Pathway Independent of Dicer Requires Argonaute2 Catalytic Activity , 2010, Science.

[3]  G. Hannon,et al.  A dicer-independent miRNA biogenesis pathway that requires Ago catalysis , 2010, Nature.

[4]  Michael C. Ostrowski,et al.  MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. , 2010, Molecular cell.

[5]  Michel Sadelain,et al.  A Genetic Strategy for Single and Combinatorial Analysis of miRNA Function in Mammalian Hematopoietic Stem Cells , 2009, Stem cells.

[6]  John McAnally,et al.  MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice , 2009, Science.

[7]  M. Medvedovic,et al.  Abstract 3026: MicroRNA Expression Profiling in the Ischemic Preconditioned Heart: Functional Role of a MiR-1/GATA-4/MiR-144, -451, and -762 Circuit , 2009 .

[8]  Peter Hoffmann,et al.  14-3-3:Shc Scaffolds Integrate Phosphoserine and Phosphotyrosine Signaling to Regulate Phosphatidylinositol 3-Kinase Activation and Cell Survival* , 2009, Journal of Biological Chemistry.

[9]  Saijuan Chen,et al.  Experimental validation and complexity of miRNA-mRNA target interaction during zebrafish primitive erythropoiesis. , 2009, Biochemical and biophysical research communications.

[10]  Jackeline Agorreta,et al.  microRNA-451 Regulates Macrophage Migration Inhibitory Factor Production and Proliferation of Gastrointestinal Cancer Cells , 2009, Clinical Cancer Research.

[11]  E. Sontheimer,et al.  Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.

[12]  P. Waterhouse,et al.  miR-451 regulates zebrafish erythroid maturation in vivo via its target gata2. , 2009, Blood.

[13]  Saijuan Chen,et al.  Mir-144 selectively regulates embryonic alpha-hemoglobin synthesis during primitive erythropoiesis. , 2009, Blood.

[14]  Louis W. Chang,et al.  Involvement of oxidative stress and activation of aryl hydrocarbon receptor in elevation of CYP1A1 expression and activity in lung cells and tissues by arsenic: an in vitro and in vivo study. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  M. Hung,et al.  A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in Cancer , 2009, Clinical Cancer Research.

[16]  Gideon Rechavi,et al.  MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. , 2008, Biochemical and biophysical research communications.

[17]  Eric C. Lai,et al.  Biological principles of microRNA-mediated regulation: shared themes amid diversity , 2008, Nature Reviews Genetics.

[18]  W. Tan,et al.  Foxo3a Inhibits Cardiomyocyte Hypertrophy through Transactivating Catalase* , 2008, Journal of Biological Chemistry.

[19]  Monika Belickova,et al.  Differential expression of microRNAs in hematopoietic cell lineages , 2008, European journal of haematology.

[20]  V. Ambros,et al.  The evolution of our thinking about microRNAs , 2008, Nature Medicine.

[21]  Christoph H. Emmerich,et al.  Phosphorylation‐dependent binding of 14‐3‐3 terminates signalling by the Gab2 docking protein , 2008, The EMBO journal.

[22]  Olga Kovalchuk,et al.  Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin , 2008, Molecular Cancer Therapeutics.

[23]  A. Brunet,et al.  The FoxO code , 2008, Oncogene.

[24]  D. Sorescu,et al.  FOXO3A Regulates Peroxiredoxin III Expression in Human Cardiac Fibroblasts* , 2008, Journal of Biological Chemistry.

[25]  Dihua Yu,et al.  14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling. , 2008, Cancer research.

[26]  Xiaowu Gai,et al.  A GATA-1-regulated microRNA locus essential for erythropoiesis , 2008, Proceedings of the National Academy of Sciences.

[27]  F. Guma,et al.  Propylthiouracil-induced congenital hypothyroidism upregulates vimentin phosphorylation and depletes antioxidant defenses in immature rat testis. , 2008, Journal of molecular endocrinology.

[28]  Huiling Xue,et al.  MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. , 2008, Blood.

[29]  F. Khuri,et al.  Down-regulation of 14-3-3ζ suppresses anchorage-independent growth of lung cancer cells through anoikis activation , 2008, Proceedings of the National Academy of Sciences.

[30]  Koichiro Muta,et al.  Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. , 2007, Biochemical and biophysical research communications.

[31]  J. Mendell,et al.  Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. , 2007, Experimental hematology.

[32]  M. Niemantsverdriet,et al.  Cellular functions of 14-3-3ζ in apoptosis and cell adhesion emphasize its oncogenic character , 2007, Oncogene.

[33]  Anton J. Enright,et al.  A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. , 2007, Genes & development.

[34]  S. Ghaffari,et al.  Foxo3 is required for the regulation of oxidative stress in erythropoiesis. , 2007, The Journal of clinical investigation.

[35]  D. Tindall,et al.  Dynamic FoxO transcription factors , 2007, Journal of Cell Science.

[36]  Chris P. Miller,et al.  MicroRNA expression dynamics during murine and human erythroid differentiation. , 2007, Experimental hematology.

[37]  Xiaoxia Qi,et al.  Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA , 2007, Science.

[38]  Mark M. Davis,et al.  miR-181a Is an Intrinsic Modulator of T Cell Sensitivity and Selection , 2007, Cell.

[39]  Meng Ling Choong,et al.  MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. , 2007, Experimental hematology.

[40]  R. Verhaak,et al.  Differential Regulation of Foxo3a Target Genes in Erythropoiesis , 2007, Molecular and Cellular Biology.

[41]  N. Rajewsky,et al.  The evolution of gene regulation by transcription factors and microRNAs , 2007, Nature Reviews Genetics.

[42]  G. McConkey,et al.  Analysis of short RNAs in the malaria parasite and its red blood cell host , 2006, FEBS letters.

[43]  M. Socolovsky,et al.  Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo. , 2006, Blood.

[44]  A. Cimini,et al.  Human glioblastoma ADF cells express tyrosinase, L‐tyrosine hydroxylase and melanosomes and are sensitive to L‐tyrosine and phenylthiourea , 2006, Journal of cellular physiology.

[45]  David Basiji,et al.  Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow. , 2006, Journal of immunological methods.

[46]  Eugene Berezikov,et al.  Cloning and expression of new microRNAs from zebrafish , 2006, Nucleic acids research.

[47]  C. Croce,et al.  MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[49]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[50]  Hao Wang,et al.  Global regulation of erythroid gene expression by transcription factor GATA-1. , 2004, Blood.

[51]  G. Chainy,et al.  Thyroid Hormone Influences Antioxidant Defense System in Adult Rat Brain , 2004, Neurochemical Research.

[52]  C. MacKintosh,et al.  Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. , 2004, The Biochemical journal.

[53]  D. Buhler,et al.  Phenylthiourea as a weak activator of aryl hydrocarbon receptor inhibiting 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 transcription in zebrafish embryo. , 2004, Biochemical pharmacology.

[54]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[55]  H. Beug,et al.  FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1 , 2004, The Journal of cell biology.

[56]  W. Ha,et al.  The differential proteome profile of stomach cancer: identification of the biomarker candidates. , 2004, Oncology research.

[57]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[58]  Patrick J. Paddison,et al.  An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo , 2003, Nature Genetics.

[59]  Geert J. P. L. Kops,et al.  Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress , 2002, Nature.

[60]  S. Nemoto,et al.  Redox Regulation of Forkhead Proteins Through a p66shc-Dependent Signaling Pathway , 2002, Science.

[61]  H. Lodish,et al.  Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. , 2001, Blood.

[62]  P. Olsson,et al.  Generating Transparent Zebrafish: A Refined Method to Improve Detection of Gene Expression During Embryonic Development , 2001, Marine Biotechnology.

[63]  S. Orkin,et al.  GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. , 1999, Blood.

[64]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[65]  M. Dottore,et al.  Identification of a 14-3-3 binding sequence in the common beta chain of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors that is serine-phosphorylated by GM-CSF. , 1999, Blood.

[66]  G. Stamatoyannopoulos,et al.  Inclusion-Body β-Thalassemia Trait , 1974 .

[67]  G. Stamatoyannopoulos,et al.  Inclusion-body beta-thalassemia trait. A form of beta thalassemia producing clinical manifestations in simple heterozygotes. , 1974, The New England journal of medicine.